| Maren Shaw, MD | |
|
2041 Georgia Ave Nw, Washington, DC 20060-0001 | |
| (202) 865-1257 | |
| Not Available |
| Full Name | Maren Shaw |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 2041 Georgia Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205039922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | D0070481 (Maryland) | Secondary |
| 207N00000X | Dermatology | MD039443 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Dermatology Of White Plains Llc | 5496037848 | 6 |
News Archive
Potentially life-threatening non-alcoholic fatty liver disease (NAFLD) in obese children has distinct characteristics, often different from those found in adults, according to a University of California, San Diego (UCSD) School of Medicine study led by Jeffrey Schwimmer, M.D., assistant professor of pediatrics.
As the panel's Nov. 23 deadline approaches and doubts about its ability for success persist, a new approach is emerging in which the panel may opt to postpone politically difficult decisions by deciding the amount of new revenue their deficit-reduction plan would require, but leaving specifics to Congress' tax-writing committees to fill in next year.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI).
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043378656 PECOS PAC ID: 3779495858 Enrollment ID: O20080519000558 |
News Archive
Potentially life-threatening non-alcoholic fatty liver disease (NAFLD) in obese children has distinct characteristics, often different from those found in adults, according to a University of California, San Diego (UCSD) School of Medicine study led by Jeffrey Schwimmer, M.D., assistant professor of pediatrics.
As the panel's Nov. 23 deadline approaches and doubts about its ability for success persist, a new approach is emerging in which the panel may opt to postpone politically difficult decisions by deciding the amount of new revenue their deficit-reduction plan would require, but leaving specifics to Congress' tax-writing committees to fill in next year.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI).
› Verified 8 days ago
| Entity Name | Integrated Dermatology Of White Plains Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225581879 PECOS PAC ID: 5496037848 Enrollment ID: O20170120000761 |
News Archive
Potentially life-threatening non-alcoholic fatty liver disease (NAFLD) in obese children has distinct characteristics, often different from those found in adults, according to a University of California, San Diego (UCSD) School of Medicine study led by Jeffrey Schwimmer, M.D., assistant professor of pediatrics.
As the panel's Nov. 23 deadline approaches and doubts about its ability for success persist, a new approach is emerging in which the panel may opt to postpone politically difficult decisions by deciding the amount of new revenue their deficit-reduction plan would require, but leaving specifics to Congress' tax-writing committees to fill in next year.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maren Shaw, MD 2041 Georgia Ave Nw, Washington, DC 20060-0001 Ph: (202) 865-6679 | Maren Shaw, MD 2041 Georgia Ave Nw, Washington, DC 20060-0001 Ph: (202) 865-1257 |
News Archive
Potentially life-threatening non-alcoholic fatty liver disease (NAFLD) in obese children has distinct characteristics, often different from those found in adults, according to a University of California, San Diego (UCSD) School of Medicine study led by Jeffrey Schwimmer, M.D., assistant professor of pediatrics.
As the panel's Nov. 23 deadline approaches and doubts about its ability for success persist, a new approach is emerging in which the panel may opt to postpone politically difficult decisions by deciding the amount of new revenue their deficit-reduction plan would require, but leaving specifics to Congress' tax-writing committees to fill in next year.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI).
› Verified 8 days ago
Dr. George Walter Turiansky, MD Dermatology Medicare: Medicare Enrolled Practice Location: Walter Reed Army Medical Center; Attn: Mchl-mao-c, 6900 Georgia Ave. Nw, Washington, DC 20307 Phone: 202-782-7341 | |
Lauren Mckelroy, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2141 K St Nw Ste 307, Washington, DC 20037 Phone: 202-293-3990 | |
Dr. Catharine Lisa Kauffman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite #210, Washington, DC 20016 Phone: 202-363-9600 Fax: 202-363-9601 | |
Dr. Melissa Bueche Scorza, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 202-782-6173 | |
Dr. Edward H Stolar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1712 Eye Street Nw, Suite 712, Washington, DC 20006 Phone: 202-659-2223 Fax: 202-659-0289 | |
Dr. Clinzo P. Mickle Ii, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 650 Pennsylvania Ave Se, Suite 420, Washington, DC 20003 Phone: 202-547-9001 | |
Dr. Urvi Pajvani Gonzales, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1120 19th St Nw, Suite 250, Washington, DC 20036 Phone: 202-955-6995 Fax: 202-955-3915 |